CN104873805A - 一种治疗感冒的中药制剂、制备方法及应用 - Google Patents
一种治疗感冒的中药制剂、制备方法及应用 Download PDFInfo
- Publication number
- CN104873805A CN104873805A CN201510237745.4A CN201510237745A CN104873805A CN 104873805 A CN104873805 A CN 104873805A CN 201510237745 A CN201510237745 A CN 201510237745A CN 104873805 A CN104873805 A CN 104873805A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine preparation
- flu
- parts
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 92
- 238000002360 preparation method Methods 0.000 title claims abstract description 72
- 239000000706 filtrate Substances 0.000 claims abstract description 29
- 239000002994 raw material Substances 0.000 claims abstract description 21
- 238000002156 mixing Methods 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 238000001914 filtration Methods 0.000 claims abstract description 11
- 238000010992 reflux Methods 0.000 claims abstract description 7
- 206010022000 influenza Diseases 0.000 claims description 61
- 239000000203 mixture Substances 0.000 claims description 21
- 241000334161 Cercis chinensis Species 0.000 claims description 13
- 229940079593 drug Drugs 0.000 claims description 9
- 241000628997 Flos Species 0.000 claims description 8
- 210000000582 semen Anatomy 0.000 claims description 8
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 7
- 230000001476 alcoholic effect Effects 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 239000002552 dosage form Substances 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 239000007901 soft capsule Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 208000022873 Ocular disease Diseases 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 11
- 241000411851 herbal medicine Species 0.000 abstract description 6
- 238000010438 heat treatment Methods 0.000 abstract description 5
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract description 4
- 244000068988 Glycine max Species 0.000 abstract description 3
- 235000010469 Glycine max Nutrition 0.000 abstract description 3
- 241000205585 Aquilegia canadensis Species 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- 241000555712 Forsythia Species 0.000 abstract 2
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 2
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 2
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 2
- 241000951473 Schizonepeta Species 0.000 abstract 2
- 240000005528 Arctium lappa Species 0.000 abstract 1
- 235000003130 Arctium lappa Nutrition 0.000 abstract 1
- 235000008078 Arctium minus Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241001506304 Kadsura japonica Species 0.000 abstract 1
- 240000003915 Lophatherum gracile Species 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 20
- 208000024891 symptom Diseases 0.000 description 20
- 208000002193 Pain Diseases 0.000 description 19
- 230000036407 pain Effects 0.000 description 19
- 201000010099 disease Diseases 0.000 description 18
- 231100000614 poison Toxicity 0.000 description 17
- 230000006870 function Effects 0.000 description 16
- 210000004072 lung Anatomy 0.000 description 15
- 206010007247 Carbuncle Diseases 0.000 description 13
- 239000008280 blood Substances 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 13
- 206010011224 Cough Diseases 0.000 description 11
- 230000008961 swelling Effects 0.000 description 10
- 239000003440 toxic substance Substances 0.000 description 10
- 206010019233 Headaches Diseases 0.000 description 8
- 206010030113 Oedema Diseases 0.000 description 8
- 231100000869 headache Toxicity 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 230000001717 pathogenic effect Effects 0.000 description 8
- 206010000087 Abdominal pain upper Diseases 0.000 description 7
- 206010037660 Pyrexia Diseases 0.000 description 7
- 210000000214 mouth Anatomy 0.000 description 7
- 239000002574 poison Substances 0.000 description 7
- 206010017553 Furuncle Diseases 0.000 description 6
- 230000001154 acute effect Effects 0.000 description 6
- 235000013399 edible fruits Nutrition 0.000 description 6
- 201000007227 lymph node tuberculosis Diseases 0.000 description 6
- 239000002398 materia medica Substances 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 5
- 206010040943 Skin Ulcer Diseases 0.000 description 5
- 241000700605 Viruses Species 0.000 description 5
- 210000000038 chest Anatomy 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 201000006549 dyspepsia Diseases 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 210000003026 hypopharynx Anatomy 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 231100000019 skin ulcer Toxicity 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 208000008454 Hyperhidrosis Diseases 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 4
- 208000001431 Psychomotor Agitation Diseases 0.000 description 4
- 206010038743 Restlessness Diseases 0.000 description 4
- 206010042674 Swelling Diseases 0.000 description 4
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 4
- 229960003321 baicalin Drugs 0.000 description 4
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 208000013219 diaphoresis Diseases 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 201000004792 malaria Diseases 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 4
- 229930182490 saponin Natural products 0.000 description 4
- 150000007949 saponins Chemical class 0.000 description 4
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 4
- -1 sterol compound Chemical class 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- 206010000060 Abdominal distension Diseases 0.000 description 3
- 206010063409 Acarodermatitis Diseases 0.000 description 3
- 206010063659 Aversion Diseases 0.000 description 3
- 206010007882 Cellulitis Diseases 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 206010012335 Dependence Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 201000000297 Erysipelas Diseases 0.000 description 3
- 206010028748 Nasal obstruction Diseases 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 241000447727 Scabies Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 208000033809 Suppuration Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 3
- 229960004949 glycyrrhizic acid Drugs 0.000 description 3
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 3
- 235000019410 glycyrrhizin Nutrition 0.000 description 3
- 208000035861 hematochezia Diseases 0.000 description 3
- 208000021760 high fever Diseases 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 206010025482 malaise Diseases 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 201000009240 nasopharyngitis Diseases 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 208000005687 scabies Diseases 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 235000018553 tannin Nutrition 0.000 description 3
- 229920001864 tannin Polymers 0.000 description 3
- 239000001648 tannin Substances 0.000 description 3
- 208000004371 toothache Diseases 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- XHXUANMFYXWVNG-ADEWGFFLSA-N (-)-Menthyl acetate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(C)=O XHXUANMFYXWVNG-ADEWGFFLSA-N 0.000 description 2
- QUAPPCXFYKSDSV-LBPRGKRZSA-N (2s)-5,7-dihydroxy-6-methoxy-2-phenyl-2,3-dihydrochromen-4-one Chemical compound C1([C@H]2OC3=CC(O)=C(C(=C3C(=O)C2)O)OC)=CC=CC=C1 QUAPPCXFYKSDSV-LBPRGKRZSA-N 0.000 description 2
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 description 2
- GRWFGVWFFZKLTI-IUCAKERBSA-N 1S,5S-(-)-alpha-Pinene Natural products CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 2
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 2
- APTNOIWSCDBIAS-UHFFFAOYSA-N 5,10,11-trihydroxy-9,9-bis(hydroxymethyl)-2,2,6a,6b,12a-pentamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid Chemical compound C1C(O)C(O)C(CO)(CO)C2CCC3(C)C4(C)CC(O)C5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C APTNOIWSCDBIAS-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- NWUMSRKLBRWRAS-UHFFFAOYSA-N Arundoin Natural products COC1CCC2(C)C(CCC3C2=CCC4(C)C5CC(C)(C)CCC5(C)CCC34C)C1(C)C NWUMSRKLBRWRAS-UHFFFAOYSA-N 0.000 description 2
- 241000246150 Cercis Species 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 241001672694 Citrus reticulata Species 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010741 Conjunctivitis Diseases 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010020565 Hyperaemia Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000006877 Insect Bites and Stings Diseases 0.000 description 2
- YNWXJFQOCHMPCK-UHFFFAOYSA-N Isoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-UHFFFAOYSA-N 0.000 description 2
- 206010023880 Laryngitis viral Diseases 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- FURUXTVZLHCCNA-UHFFFAOYSA-N Liquiritigenin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-UHFFFAOYSA-N 0.000 description 2
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 2
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 2
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 2
- XQWFHGOIUZFQPJ-USTPAGJBSA-N Neoisoliquiritigenin Natural products O=C(/C=C/c1ccc(O)cc1)c1c(O)cc(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O2)cc1 XQWFHGOIUZFQPJ-USTPAGJBSA-N 0.000 description 2
- XQWFHGOIUZFQPJ-LXGDFETPSA-N Neoisoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1O)=CC=C1C(=O)\C=C\C1=CC=C(O)C=C1 XQWFHGOIUZFQPJ-LXGDFETPSA-N 0.000 description 2
- XQWFHGOIUZFQPJ-UHFFFAOYSA-N Neoisoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1O)=CC=C1C(=O)C=CC1=CC=C(O)C=C1 XQWFHGOIUZFQPJ-UHFFFAOYSA-N 0.000 description 2
- PTPHDVKWAYIFRX-UHFFFAOYSA-N Palmatine Natural products C1C2=C(OC)C(OC)=CC=C2C=C2N1CCC1=C2C=C(OC)C(OC)=C1 PTPHDVKWAYIFRX-UHFFFAOYSA-N 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 206010039101 Rhinorrhoea Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 206010047473 Viral pharyngitis Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 2
- RTIXKCRFFJGDFG-UHFFFAOYSA-N chrysin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=CC=C1 RTIXKCRFFJGDFG-UHFFFAOYSA-N 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- 208000030533 eye disease Diseases 0.000 description 2
- 210000000744 eyelid Anatomy 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- JBQATDIMBVLPRB-UHFFFAOYSA-N isoliquiritigenin Natural products OC1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 JBQATDIMBVLPRB-UHFFFAOYSA-N 0.000 description 2
- YNWXJFQOCHMPCK-LXGDFETPSA-N isoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-LXGDFETPSA-N 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- FURUXTVZLHCCNA-AWEZNQCLSA-N liquiritigenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-AWEZNQCLSA-N 0.000 description 2
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 208000010753 nasal discharge Diseases 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- LKOJGSWUMISDOF-UHFFFAOYSA-N oroxylin A Chemical compound C=1C(=O)C2=C(O)C(OC)=C(O)C=C2OC=1C1=CC=CC=C1 LKOJGSWUMISDOF-UHFFFAOYSA-N 0.000 description 2
- QUCQEUCGKKTEBI-UHFFFAOYSA-N palmatine Chemical compound COC1=CC=C2C=C(C3=C(C=C(C(=C3)OC)OC)CC3)[N+]3=CC2=C1OC QUCQEUCGKKTEBI-UHFFFAOYSA-N 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- HKZQJZIFODOLFR-UHFFFAOYSA-N piperitenone Chemical compound CC(C)=C1CCC(C)=CC1=O HKZQJZIFODOLFR-UHFFFAOYSA-N 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- NDVASEGYNIMXJL-UHFFFAOYSA-N sabinene Chemical compound C=C1CCC2(C(C)C)C1C2 NDVASEGYNIMXJL-UHFFFAOYSA-N 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 235000015096 spirit Nutrition 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 206010042772 syncope Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 201000002327 urinary tract obstruction Diseases 0.000 description 2
- 201000008195 viral laryngitis Diseases 0.000 description 2
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical group CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- NFLGAXVYCFJBMK-DTWKUNHWSA-N (+)-menthone Chemical group CC(C)[C@H]1CC[C@H](C)CC1=O NFLGAXVYCFJBMK-DTWKUNHWSA-N 0.000 description 1
- NDVASEGYNIMXJL-NXEZZACHSA-N (+)-sabinene Natural products C=C1CC[C@@]2(C(C)C)[C@@H]1C2 NDVASEGYNIMXJL-NXEZZACHSA-N 0.000 description 1
- NFLGAXVYCFJBMK-IUCAKERBSA-N (-)-isomenthone Chemical compound CC(C)[C@@H]1CC[C@H](C)CC1=O NFLGAXVYCFJBMK-IUCAKERBSA-N 0.000 description 1
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 1
- 239000001605 (5-methyl-2-propan-2-ylcyclohexyl) acetate Substances 0.000 description 1
- UPLPHRJJTCUQAY-WIRWPRASSA-N 2,3-thioepoxy madol Chemical compound C([C@@H]1CC2)[C@@H]3S[C@@H]3C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@](C)(O)[C@@]2(C)CC1 UPLPHRJJTCUQAY-WIRWPRASSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- NYCXYKOXLNBYID-UHFFFAOYSA-N 5,7-Dihydroxychromone Natural products O1C=CC(=O)C=2C1=CC(O)=CC=2O NYCXYKOXLNBYID-UHFFFAOYSA-N 0.000 description 1
- OOCLVMCVOWKECB-UHFFFAOYSA-N 6,6-dimethylbicyclo[3.1.1]heptane-4-carbaldehyde Chemical compound C1C2C(C)(C)C1CCC2C=O OOCLVMCVOWKECB-UHFFFAOYSA-N 0.000 description 1
- NVEQFIOZRFFVFW-UHFFFAOYSA-N 9-epi-beta-caryophyllene oxide Natural products C=C1CCC2OC2(C)CCC2C(C)(C)CC21 NVEQFIOZRFFVFW-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000005584 Alcoholic Intoxication Diseases 0.000 description 1
- 206010001908 Amblyopia congenital Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010002953 Aphonia Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 241000208843 Arctium Species 0.000 description 1
- MRNPHCMRIQYRFU-KXUMSINMSA-N Arundoin Chemical compound C([C@]1(C)[C@@H](C(C)C)CC[C@H]1[C@]1(C)CC=C23)C[C@]1(C)[C@H]3CC[C@@H]1[C@]2(C)CC[C@H](OC)C1(C)C MRNPHCMRIQYRFU-KXUMSINMSA-N 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000003910 Baronia <angiosperm> Species 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- 241000208671 Campanulaceae Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000208828 Caprifoliaceae Species 0.000 description 1
- 206010007747 Cataract congenital Diseases 0.000 description 1
- 235000006228 Cercis occidentalis Nutrition 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- JZVFJDZBLUFKCA-ZXLWUMLCSA-N Chondrillasterol Natural products CC[C@H](C=C[C@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C JZVFJDZBLUFKCA-ZXLWUMLCSA-N 0.000 description 1
- 206010009152 Chronic tonsillitis Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- MRNPHCMRIQYRFU-UWAWSDATSA-N Cylindrin Chemical compound C([C@@]1(C)[C@H](C(C)C)CC[C@@H]1[C@@]1(C)CC=C23)C[C@@]1(C)[C@@H]3CC[C@@H]1[C@]2(C)CC[C@H](OC)C1(C)C MRNPHCMRIQYRFU-UWAWSDATSA-N 0.000 description 1
- BRQBMPGDACUHNR-UHFFFAOYSA-N Cylindrin Natural products COC1CCC2(C)C(CCC3C2=CCC4(C)C5CCC(C(C)C)C5CCC34C)C1(C)C BRQBMPGDACUHNR-UHFFFAOYSA-N 0.000 description 1
- XHXUANMFYXWVNG-UHFFFAOYSA-N D-menthyl acetate Natural products CC(C)C1CCC(C)CC1OC(C)=O XHXUANMFYXWVNG-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 229930191995 Dihydrooroxylin Natural products 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- QNGQIURXCUHNAT-UHFFFAOYSA-N Eucarvone Chemical compound CC1=CC=CC(C)(C)CC1=O QNGQIURXCUHNAT-UHFFFAOYSA-N 0.000 description 1
- OPQCAZJRIRHZQK-UHFFFAOYSA-N Eucarvone Natural products CC1=CC=CCC(C)(C)C1=O OPQCAZJRIRHZQK-UHFFFAOYSA-N 0.000 description 1
- 241000221079 Euphorbia <genus> Species 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 206010067715 Gastrointestinal sounds abnormal Diseases 0.000 description 1
- 206010018286 Gingival pain Diseases 0.000 description 1
- 206010018291 Gingival swelling Diseases 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 206010020675 Hypermetropia Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- MXTLAHSTUOXGQF-UHFFFAOYSA-O Jatrorrhizine Chemical compound COC1=CC=C2C=C3C(C=C(C(=C4)O)OC)=C4CC[N+]3=CC2=C1OC MXTLAHSTUOXGQF-UHFFFAOYSA-O 0.000 description 1
- 244000188405 Knoxia valerianoides Species 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 241001234819 Limacia <gastropod> Species 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 241000607292 Maguireothamnus speciosus Species 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010028116 Mucosal inflammation Diseases 0.000 description 1
- 201000010927 Mucositis Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- HJBUYKZTEBZNSH-ZRWXNEIDSA-N Neoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(C(=O)C[C@H](O2)C=3C=CC(O)=CC=3)C2=C1 HJBUYKZTEBZNSH-ZRWXNEIDSA-N 0.000 description 1
- HJBUYKZTEBZNSH-ONJCETCRSA-N Neoliquiritin Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(C(=O)C[C@@H](O2)C=3C=CC(O)=CC=3)C2=C1 HJBUYKZTEBZNSH-ONJCETCRSA-N 0.000 description 1
- 241000207834 Oleaceae Species 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- JYDNKGUBLIKNAM-UHFFFAOYSA-N Oxyallobutulin Natural products C1CC(=O)C(C)(C)C2CCC3(C)C4(C)CCC5(CO)CCC(C(=C)C)C5C4CCC3C21C JYDNKGUBLIKNAM-UHFFFAOYSA-N 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- HFNGSIBHHMFWQB-UHFFFAOYSA-N Platycogenic acid A Natural products C1C(O)C(O)C(CO)(C(O)=O)C2CCC3(C)C4(C)CC(O)C5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C HFNGSIBHHMFWQB-UHFFFAOYSA-N 0.000 description 1
- DGNAEYFEAUVDAJ-UHFFFAOYSA-N Platycogenic acid B Natural products CC12CC(O)C(O)C(C)(C(O)=O)C1CCC1(C)C2CC=C2C3CC(C)(C)C(O)CC3(C(O)=O)C(O)CC21C DGNAEYFEAUVDAJ-UHFFFAOYSA-N 0.000 description 1
- 208000002151 Pleural effusion Diseases 0.000 description 1
- 206010051986 Pneumatosis Diseases 0.000 description 1
- JZVFJDZBLUFKCA-INYURWPISA-N Poriferasta-7,22E-dien-3beta-ol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)/C=C/[C@H](CC)C(C)C)CC[C@H]33)C)C3=CC[C@H]21 JZVFJDZBLUFKCA-INYURWPISA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000167686 Reichardia Species 0.000 description 1
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 description 1
- 241001423398 Ruscus hypoglossum Species 0.000 description 1
- YSKVBPGQYRAUQO-UZSYLJJSSA-N Schottenol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)CC[C@@H](CC)C(C)C)CC[C@H]33)C)C3=CC[C@H]21 YSKVBPGQYRAUQO-UZSYLJJSSA-N 0.000 description 1
- YSKVBPGQYRAUQO-UHFFFAOYSA-N Schottenol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CCC21 YSKVBPGQYRAUQO-UHFFFAOYSA-N 0.000 description 1
- 206010039705 Scleritis Diseases 0.000 description 1
- 241000239226 Scorpiones Species 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 229930192484 Skullcapflavone Natural products 0.000 description 1
- CZRGNFVQUYWGKP-UHFFFAOYSA-N Skullcapflavone I Natural products COC=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=CC=C1O CZRGNFVQUYWGKP-UHFFFAOYSA-N 0.000 description 1
- HKOIDIVCPUDLBS-UHFFFAOYSA-N Skullcapflavone II Natural products Oc1cccc(O)c1C2=CC(=O)c3c(O)c(O)c(O)c(O)c3O2 HKOIDIVCPUDLBS-UHFFFAOYSA-N 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 244000290970 Tetrapanax papyrifer Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- BJBKXYIIWYIZCX-UHFFFAOYSA-N Trigraecum Natural products C1=C(O)C(OC)=CC(C(C=2)=O)=C1OC=2C1=CC=CC=C1 BJBKXYIIWYIZCX-UHFFFAOYSA-N 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- KGGGRGBDMBZXKF-UHFFFAOYSA-N Virganreagenin G Natural products C1C(O)C(O)C(C)(CO)C2CCC3(C)C4(C)CC(O)C5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C KGGGRGBDMBZXKF-UHFFFAOYSA-N 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 208000034699 Vitreous floaters Diseases 0.000 description 1
- HIMJIPRMECETLJ-UHFFFAOYSA-N Wogonin Natural products COc1cc(O)c(O)c2C(=O)C=C(Oc12)c3ccccc3 HIMJIPRMECETLJ-UHFFFAOYSA-N 0.000 description 1
- LNOHXHDWGCMVCO-UHFFFAOYSA-N Wogonoside Natural products C1=C(O)C(C(C=C(O2)C=3C=CC=CC=3)=O)=C2C(OC)=C1OC1OC(C(O)=O)C(O)C(O)C1O LNOHXHDWGCMVCO-UHFFFAOYSA-N 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- FAMPSKZZVDUYOS-UHFFFAOYSA-N alpha-Caryophyllene Natural products CC1=CCC(C)(C)C=CCC(C)=CCC1 FAMPSKZZVDUYOS-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- JZVFJDZBLUFKCA-UTQQLQBSSA-N alpha-spinasterol Natural products CC[C@H](C=C[C@H](C)[C@H]1CC[C@H]2C3=CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C JZVFJDZBLUFKCA-UTQQLQBSSA-N 0.000 description 1
- KQAZVFVOEIRWHN-UHFFFAOYSA-N alpha-thujene Natural products CC1=CCC2(C(C)C)C1C2 KQAZVFVOEIRWHN-UHFFFAOYSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- VBIXEXWLHSRNKB-UHFFFAOYSA-N ammonium oxalate Chemical compound [NH4+].[NH4+].[O-]C(=O)C([O-])=O VBIXEXWLHSRNKB-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 210000001099 axilla Anatomy 0.000 description 1
- 239000010231 banlangen Substances 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-DTEWXJGMSA-N beta-D-galacturonic acid Chemical compound O[C@@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-DTEWXJGMSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- FVWJYYTZTCVBKE-ROUWMTJPSA-N betulin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(CO)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C FVWJYYTZTCVBKE-ROUWMTJPSA-N 0.000 description 1
- MVIRREHRVZLANQ-UHFFFAOYSA-N betulin Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C2CC=C4C5C(CCC5(CO)CCC34C)C(=C)C)C1(C)C MVIRREHRVZLANQ-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 229930006739 camphene Natural products 0.000 description 1
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 1
- 239000010238 camphora Substances 0.000 description 1
- 229940025250 camphora Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229940117948 caryophyllene Drugs 0.000 description 1
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000021735 chronic enteritis Diseases 0.000 description 1
- 235000015838 chrysin Nutrition 0.000 description 1
- 229940043370 chrysin Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- AALLCALQGXXWNA-DURQJQQASA-N columbin Chemical compound C=1([C@@H]2C[C@@]3([C@H](C(=O)O2)CC[C@@]2(C)[C@]4(O)C(=O)O[C@@H](C=C4)[C@@H]32)C)C=COC=1 AALLCALQGXXWNA-DURQJQQASA-N 0.000 description 1
- OKIIUWUOOIYUGL-UHFFFAOYSA-N columbin Natural products OC12C=CC(OC1=O)C3C4CC(OC(=O)C4CCC23)c5cocc5 OKIIUWUOOIYUGL-UHFFFAOYSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 108010089310 cylindrin Proteins 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- YSKVBPGQYRAUQO-UBCZCFGNSA-N delta7 Stigmastenol Natural products O[C@@H]1C[C@@H]2[C@@](C)([C@@H]3C([C@H]4[C@@](C)([C@@H]([C@@H](CC[C@H](C(C)C)CC)C)CC4)CC3)=CC2)CC1 YSKVBPGQYRAUQO-UBCZCFGNSA-N 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 208000002296 eclampsia Diseases 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- XTLWNMXYCHABQH-UHFFFAOYSA-N germanicol Natural products CC1(C)CCC2(C)CCC3(C)C(CCC4(C)C5(C)CCC(O)C(C)(C)C5CCC34C)C2=C1 XTLWNMXYCHABQH-UHFFFAOYSA-N 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000008025 hordeolum Diseases 0.000 description 1
- 230000004305 hyperopia Effects 0.000 description 1
- 201000006318 hyperopia Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 201000001371 inclusion conjunctivitis Diseases 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- AALLCALQGXXWNA-UHFFFAOYSA-N isocolumbin Natural products O1C(=O)C(CCC2(C)C3(O)C(=O)OC(C=C3)C32)C3(C)CC1C=1C=COC=1 AALLCALQGXXWNA-UHFFFAOYSA-N 0.000 description 1
- SEZLYIWMVRUIKT-UHFFFAOYSA-N isopiperitenone Natural products CC(=C)C1CCC(C)=CC1=O SEZLYIWMVRUIKT-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 230000004379 myopia Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- XTDAUCLSJYHNGJ-UHFFFAOYSA-N platycogenic acid C Natural products CC12CC(O)C(O)C(C)(C)C1CCC1(C)C2CC=C2C3CC(C)(C)C(O)CC3(C(O)=O)C(O)CC21C XTDAUCLSJYHNGJ-UHFFFAOYSA-N 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229940056692 resinol Drugs 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 description 1
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 description 1
- 229930006696 sabinene Natural products 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- GMQFOKBGMKVUQZ-UHFFFAOYSA-N scullcapflavone II Chemical compound COC1=CC=CC(O)=C1C1=CC(=O)C2=C(O)C(OC)=C(OC)C(OC)=C2O1 GMQFOKBGMKVUQZ-UHFFFAOYSA-N 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- GGGUGZHBAOMSFJ-GADYQYKKSA-N taraxerol Chemical compound CC([C@@H]1CC2)(C)[C@@H](O)CC[C@]1(C)[C@@H]1[C@]2(C)C2=CC[C@@]3(C)CCC(C)(C)C[C@H]3[C@]2(C)CC1 GGGUGZHBAOMSFJ-GADYQYKKSA-N 0.000 description 1
- HYTFUKZLSYXRDX-UHFFFAOYSA-N taraxerol Natural products CC1CCCC2C3(C)CCC4(C)C5CC(C)(C)CCC5(C)C=CC4(C)C3C(O)CC12C HYTFUKZLSYXRDX-UHFFFAOYSA-N 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 206010044325 trachoma Diseases 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- XLTFNNCXVBYBSX-UHFFFAOYSA-N wogonin Chemical compound COC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=CC=C1 XLTFNNCXVBYBSX-UHFFFAOYSA-N 0.000 description 1
- LNOHXHDWGCMVCO-NTKSAMNMSA-N wogonin 7-O-beta-D-glucuronide Chemical compound C1=C(O)C(C(C=C(O2)C=3C=CC=CC=3)=O)=C2C(OC)=C1O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LNOHXHDWGCMVCO-NTKSAMNMSA-N 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N β-pinene Chemical compound C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于一种中草药技术领域,具体是涉及一种治疗感冒的中药制剂及应用,所述治疗感冒的中药制剂的原料包括以下成分:金银花、连翘、薄荷、荆芥、淡豆豉、牛蒡子、桔梗、淡竹叶和甘草,制备方法,将所述各原料组份的金银花、连翘、薄荷、荆芥、淡豆豉、黄芩、青皮和紫荆皮混合均匀,粉碎,加入乙醇溶液回流提取,过滤,得到滤液I和滤渣,将所述滤渣和水混合,浸泡,过滤,得到滤液II,将上述得到的滤液I和滤液II混合,得到滤液;将所述原料的其他组份混合均匀,加入水中,加热,过滤,得到滤液,将上述得到的滤液混合,按照中药制剂的常规制备方法得到治疗感冒的中药制剂,本发明用于治疗感冒,疗效显著,利用效率高。
Description
技术领域
本发明属于一种中草药技术领域,具体是涉及一种治疗感冒的中药制剂、制备方法及应用。
背景技术
中医理论认为,感冒时感受触冒风邪而导致的常见外感疾病。其中,病情轻着多为感受当令之气,一般称为伤风;病情较重者,常为感受非时之邪,又称为重伤风,在同一个时期广泛流行,患者症状多相类似,则成为流行感冒。
感冒是由外感六淫,时兴病毒侵入人体而致病,一年四季均可发生,尤以冬春二季更为多见。风味六淫之首,流动于四时之中,为发病的先导。又因四时六气各有偏盛,故临床表现为不同的症状,如深秋冬令之时,风邪易与寒相合,出现风寒感冒症状。春夏温暖季节,风邪容易与热相合,出现风热感冒症状。此外,以上二症,也可夹带湿气或者兼具燥热,若时行病毒伤人,则病情一般较重而多变,往往相互传染,广泛流行。正如隋代《诸病源候论·时气病诸侯》所说:“夫时气病者,此皆因岁时不和,温凉失节,人感乖戾之气而生,病者多相染易。”
感冒的基本病理是人体防卫机体的功能减弱,外邪侵染而致病。若气候突变,冷热失常,六淫之邪肆虐,卫外之气失于调节,人体不能应变,因而受邪发病,属时行病毒为患者,多造成广泛流行,若生活起居不当,贪凉露宿,冒风淋雨,衣帽失当,过度劳倦,而寒温失调,以致营卫失和,外邪内入而为病。对于体质偏弱,或者肺有宿邪之人,尤其容易造成邪犯肺腑,卫表不和而罹患感冒。
风性清扬,为病多犯人体的上焦肺卫。外邪侵犯人体的途径有2个,即从口鼻进入或者从皮毛内侵。如《素问·太阴阳明》篇指出,“伤于风者,上先受之。”肺处胸中,主司呼吸,吼为其系,开窍于鼻,外合皮毛,职主卫外,为人身之篱笆。一旦外邪从口鼻或皮毛入侵,肺腑首当其冲,随之出现卫表不和及上焦肺腑失常的症状,由于外气束缚,郁于肌肤,阻遇人体卫气的正常宣发,肌表不得卫阳之温煦,所述出现恶寒的感觉,又因为卫阳还具有抗御外邪的功能,外邪入侵,卫气奋起相抗,正邪争斗,故引起发热,血脉也随之鼓动于外,故又见浮脉。外邪郁表,阻滞经络,故经气不得通畅,不通则痛,故引起头身疼痛,关节酸楚,其兼表湿者,酸胀重著之感更为明显。邪犯肺窍,或皮毛之邪内传于肺,因而肺气失宣,则可引起咽喉痒痛,鼻塞流涕,喷嚏,咳嗽等症状。治疗宜发表解毒,开宣肺气,利咽通窍,则感冒可除。
感冒是一种常见的临床疾病,根据病情的轻重和发病情况,以及分离出的病毒的不同,又可以分为普通感冒和流行性感冒,感冒不仅影响人们正常的工作,学习和生活,还可以引起多种严重的合并症状或者并发症,甚至导致死亡。
感冒的发病率高,几乎每个年龄的人群,一年四季都可以发病,尤其是以冬天和春天较高。其对小儿,老年体弱多病者威胁最大,特别是流行性感冒,常爆发流行,迅速传染,突然起病,症状严重,甚至导致死亡,而每年的流行性感冒,都会给社会带来巨大的经济损失,而且也造成了不同程度的超额死亡。据资料报道,在过去25年的流感发病季节中,美国的住院率最高达到270/10万,年均死亡2万人,经济损失达30-50亿美金。
随着现代生活节奏的加快,人们工作压力增加,免疫功能逐渐下降,感冒的发病率呈现上升的趋势,而感冒的发病多由细菌和病毒合并感冒引起,病人长期服用一种抗感冒的药物,久而久之,细菌则会对此药物产生耐药性,致使临床效果不佳。
中药是一种对身体损害最小的药物,具有清热解毒和抗病毒作用的中药是目前常用的治疗感冒的药物,有助于改善症状,缩短病程。小柴胡冲剂、板蓝根冲剂应用较为广泛。但是这些中药只是有着预防的效果,对感冒,尤其是重症感冒的效果不大。
另外,在传统中医的组方临床应用中,一般采用配方制,即医生开好处方后,而抓配的过程由制药房完成,这样的流程使得药物的配比不精准,往往达不到最好的疗效。
发明内容
本发明的主要目的在于提供一种治疗感冒的中药制剂、制备方法及应用。本发明的中药制剂用于治疗感冒,疗效显著,利用效率高。
本发明通过以下技术方案解决上述技术问题:
本发明的目的之一在于,提供一种治疗感冒的中药制剂,所述治疗感冒的中药制剂的原料包括以下成分:金银花、连翘、薄荷、荆芥、淡豆豉、牛蒡子、桔梗、淡竹叶和甘草。
优选的,所述治疗感冒的中药制剂的原料包括以下重量份的各成分:金银花20份、连翘20份、薄荷12份、荆芥8份、淡豆豉l0份、牛蒡子12份、桔梗12份、淡竹叶8份和甘草10份。
优选的,所述治疗感冒的中药制剂的原料还包括以下重量份的各成分:
黄芩15-30份,通草10-20份,大戟10-20份,白豆蔻5-10份,金果榄5-10份,青皮3-5份,紫荆皮1-5份。
优选的,所述治疗感冒的中药制剂的原料还包括以下重量份的各成分:
黄芩15-20份,通草15-20份,大戟10-15份,白豆蔻5-10份,金果榄5-10份,青皮3-5份,紫荆皮1-5份。
优选的,所述治疗感冒的中药制剂的原料还包括以下重量份的各成分:
黄芩15-18份,通草18-20份,大戟13-15份,白豆蔻5-8份,金果榄5-8份,青皮3-5份,紫荆皮1-2份。
优选的,所述治疗感冒的中药制剂的原料还包括以下重量份的各成分:
黄芩18份,通草18份,大戟13份,白豆蔻8份,金果榄5份,青皮3份,紫荆皮2份。
本发明还提供一种所述治疗感冒的中药制剂的制备方法,步骤为,将所述原料各组份的金银花、连翘、薄荷、荆芥、淡豆豉、黄芩、青皮和紫荆皮混合均匀,粉碎,加入乙醇溶液回流提取,过滤,得到滤液I和滤渣,将所述滤渣和水混合,在50-60摄氏度下浸泡3-4小时,过滤,得到滤液II,将上述得到的滤液I和滤液II混合,得到滤液;将所述原料的其他各组份混合均匀,加入水中,在90-100摄氏度下加热,过滤,得到滤液,将上述得到的滤液混合,按照中药制剂的常规制备方法得到治疗感冒的中药制剂。
优选的,所述粉碎后的粉末通过的目数为30-40目,乙醇溶液的体积浓度为70-80%,所述回流提取的时间为2-4小时,所述滤渣和水混合,在55-60摄氏度下浸泡3-4小时。
优选的,所述中药制剂的剂型为片剂、胶囊剂、软胶囊剂或颗粒剂。
本发明还提供一种治疗感冒的中药制剂在制备治疗眼病的药物中的应用。
以下针对上述成分及其性质做如下进一步说明:
本发明中,所述金银花,为忍冬科植物忍冬的花蕾,花含木犀草素、肌醇约1%及皂甙、鞣质等,功能主治:清热解毒,凉散风热。用于痈肿疔疮,喉痹,丹毒,热血毒痢,风热感冒,温病发热。
本发明中,所述连翘,为木犀科植物连翘的果实,果实含连翘酚、甾醇化合物、皂甙(无溶血性)及黄酮醇甙类、马苔树脂醇甙等。果皮含齐墩果酸。青连翘含皂甙4.89%,生物碱0.2%。功能主治:清热,解毒,散结,消肿。治温热,丹毒,斑疹,痈疡肿毒,瘰疬,小便淋闭。《日华子本草》:“通小肠,排脓。治疮疖,止痛,通月经。”《本经》:“主寒热,鼠痿,瘰疬,痈肿恶疮,瘿瘤,结热。”《药性论》:“主通利五淋,小便不通,除心家客热。”李杲:“散诸经血结气聚;消肿。”关于宜忌,《本草经疏》:“痈疽巳溃勿服,大热由于虚者勿服,脾胃薄弱易于作泄者勿服。”
本发明中,所述薄荷,为唇形科植物薄荷或家薄荷的全草或叶,新鲜叶含挥发油0.8~1%,干茎叶含1.3~2%。油中主成分为薄荷醇,含量约77~78%,其次为薄荷酮,含量为8~12%,,还含乙酸薄荷酯、莰烯、柠檬烯、异薄荷酮、蒎烯、薄荷烯酮、树脂及少量鞣质、迷迭香酸,功能主治:疏风,散热,辟秽,解毒。治外感风热,头痛,目赤,咽喉肿痛,食滞气胀,口疮,牙痛,疮疥,瘾疹。《药性论》:“去愤气,发毒汗,破血止痢,通利关节。”《千金·食治》:“却肾气,令人口气香洁。主辟邪毒,除劳弊。”孙思邀:“煎汤洗漆疮。”《唐本草》:“主贼风,发汗。(治)恶气腹胀满。霍乱。宿食不消,下气。”《食疗本草》:“杵汁服,去心脏风热。”《食性本草》:“能引诸药入营卫。疗阴阳毒、伤寒头痛。”《日华子本草》:“治中风失音,吐痰。除贼风。疗心腹胀。下气、消宿食及头风等。”《本草图经》:“治伤风、头脑风,通关格,小儿风涎。”《本草衍义》:“小儿惊风,壮热,须此引药;治骨蒸劳热,用其汁与众药为膏。”
本发明中,所述荆芥,为唇形科植物荆芥的全草,含挥发油1.8%,油中主成分为右旋薄荷酮、消旋簿荷酮、少量右旋柠檬烯,功能主治:祛风,理血;炒炭止血。治感冒发热,头痛,咽喉肿痛,中风口噤,吐血,衄血,便血;崩漏,产后血晕;痈肿,疮疥,瘰疬。荆芥穗效用相同,惟发散之力较强。《本经》:“主寒热,鼠瘘,瘰疬生疮,破结聚气,下瘀血,除湿痹。”《药性论》:“治恶风贼风,口面歪邪,遍身顽痹,心虚忘事,益力添糟。主辟邪毒气,除劳,治丁肿;取一握切,以水五升,煮取二升,冷分二服,主通利血脉,传送五脏不足气,能发汗,除冷风;又捣末和醋封毒肿。”
本发明中,所述淡豆豉,为豆科植物大豆的种子经蒸罨加工而成。功能主治:解表,除烦,宣郁,解毒。治伤寒热病,寒热,头痛,烦躁,胸闷。《别录》:“主伤寒头痛寒热,瘴气恶毒,烦躁满闷,虚劳喘吸,两脚疼冷。”《药性论》:“治时疾热病发汗;熬末,能止盗汗,除烦;生捣为丸服,治寒热风,胸中生疮;煮服,治血痢腹痛。”
本发明中,所述牛蒡子,为菊科二年生草本植物牛蒡(学名:Arctium lappaL.)的干燥成熟果实,味辛;苦;性寒。归肺;胃经。《别录》:“味辛,平。”《本草拾遗》:“味苦。”《珍珠囊》:“辛,纯阳。”《医学启源》:“《主治秘要》云:辛,温。”
本发明中,所述桔梗,为桔梗科植物桔梗的根。根含皂甙,已知其成分有远志酸,桔梗皂甙元及葡萄糖。又含菠菜甾醇、α-菠菜甾莳-β-D-葡萄糖甙、Δ7-豆甾烯醇、白桦脂醇,并含菊糖、桔梗聚糖。又从桔梗得到三个三萜烯类物质:桔梗酸A、B、及C。花含飞燕草素-3二-咖啡酰芦丁糖-5-葡萄糖甙。功能主治:开宣肺气,祛痰排脓。治外感咳嗽,咽喉肿痛,肺痈吐脓,胸满胁痛,痢疾腹痛。《本经》:“主胸胁痛如刀刺,腹满,肠鸣幽幽,惊恐悸气。”《别录》:“利五脏肠胃,补血气,除寒热、风痹,温中消谷,疗喉咽痛。”
本发明中,所述淡竹叶,为禾本科植物淡竹叶的全草。茎、叶含三萜化合物:芦竹素,印白茅素,蒲公英赛醇和无羁萜。另谓地上部分含酚性成分、氨基酸、有机酸、糖类。功能主治:清心火,除烦热,利小便。治热病口渴,心烦,小便赤涩,淋浊,口糜舌疮,牙龈肿痛。《纲目》:“去烦热,利小便,清心。”《生草药性备要》:“消痰止渴,除上焦火,明眼目,利小便,治白浊,退热,散痔疮毒。”
本发明中,所述甘草,为豆科植物甘草的根及根状茎。甘草根及根茎含甘草甜素,为甘草酸(glycyrrhizicacid)的钾、钙盐。尚含甘草甙(liquiritin)、甘草甙元(liquiritigenin)、异甘草甙(isoliquiritin)、异甘草元(isoliquritigenin)、新甘草甙(neo-liquiritin)、新异甘草甙(neoiso-liquiritin)等。功能主治:和中缓急,润肺,解毒,调和诸药。炙用,治脾胃虚弱,食少,腹痛便溏,劳倦发热,肺痿咳嗽,心悸,惊痫;生用,治咽喉肿痛,消化性溃疡,痈疽疮疡,解药毒及食物中毒。《本经》:“主五脏六府寒热邪气,坚筋骨,长肌肉,倍力,金疮肿,解毒。”《别录》:“温中下气,烦满短气,伤脏咳嗽,止渴,通经脉,利血气,解百药毒。”
本发明中,所述黄芩,为唇形科植物黄芩的根,含黄酮类化合物:黄芩素,黄芩新素,黄芩甙(baicalin),汉黄芩素,汉黄芩甙,木蝴蝶素A,7-甲氧基黄芩素,黄芩黄酮,二氢木蝴蝶素,白杨素等有效成分。功能主治:泻实火,除湿热,止血,安胎。治壮热烦渴,肺热咳嗽,湿热泻痢,黄疸,热淋,吐、衄、崩、漏,目赤肿痛,胎动不安,痈肿疔疮。《本经》:“主诸热黄疸,肠澼,泄利,逐水,下血闭,(治)恶疮,疽蚀,火疡”。《别录》:“疗痰热,胃中热,小腹绞痛,消谷,利小肠,女子血闭,淋露下血,小儿腹痛”。
本发明中,所述通草,为五加科植物通脱木的茎髓,含灰分5.95%、脂肪1.07%、蛋白质1.11%、粗纤维48.73%、戊聚糖5.83%。尚含糖醛酸28.04%,其一部分存在于聚β-D-半乳糖醛酸(这种多糖溶于草酸铵溶液)。另含溶于入NaOH溶液的多糖,其水解产物中含半乳糖醛酸、半乳糖、葡萄糖和木糖。功能主治:泻肺,利小便,下乳汁。治小便不利,淋病,水肿,产妇乳汁不通,目昏,鼻塞。《医学启源》:“除水肿癃闭,治五淋。《主治秘诀》云,泻肺。”《日华子本草》:“明目,退热,催生,下胞,下乳。”《长沙药解》:“通经闭,疗黄疸,消痈疽,利鼻痈,除心烦。”
本发明中,所述大戟为大戟科植物大截或茜草科植物红芽大戟的根。功能主治:泻水沈,利二便。治水肿,水臌,痰饮,瘰疬,痈疽肿毒。《本经》:“主十二水,腹满急痛,积聚,中风皮肤疼厢,吐逆。”《别录》:“主颈腋痈肿,头痛,发汗,利大小肠。”《药性论》:“下恶血癖块,腹内雷鸣,通月水,善治瘀血,能堕胎孕。”《日华子本草》:“泻毒药,泄天行黄病、温疟,破癥瘕。”《现代实用中药》:“用于壮实体质之腹水,全身水肿。胸肋膜积水等。”
本发明中,所述白豆蔻,为姜科植物白豆蔻的果实,果实含挥发油,其中有d-龙脑、d-樟脑、葎草烯及其环氧化物、1,8-桉叶素、α-及δ-拍帕烯、α-及β-蒎烯、石竹烯、月桂烯、桃金娘醛、葛缕酮、松油烯-4-醇、香桧烯等。功能主治:行气,暖胃,消食,宽中。治气滞,食滞,胸闷,腹胀,噫气,噎膈,吐逆,反胃,疟疾。《开宝本草》:“主积冷气,止吐逆,反胃,消谷下气。”《医学启源》:“《主治秘要》云,肺金本药,散胸中滞气,感寒腹痛,温暖脾胃,赤眼暴发,白睛红者。”《纲目》:“治噎膈,除疟疾,寒热,解酒毒。”《本草备要》:“除寒燥湿,化食宽膨。”
本发明中,所述金果榄,为防己科植物金果榄或青牛胆的块根,含青牛胆苦素(tinosporine,columbin)、巴马亭(palmatine)、药根碱等。功能主治:清热解毒,治急慢性扁桃体炎,急性咽喉炎,口腔炎,腮腺炎,乳腺炎,阑尾炎,痈疽疔疮,急慢性肠炎,菌痢,胃痛,热嗽失音。《药性考》:“解毒。咽喉痹急,口烂宜服。疽痈发背,焮赤疔瘯,蛇蝎虫伤,磨涂。治目痛,耳胀,热嗽,岚瘴,吐衄,一切外症。”《柑园小识》:“祛内外结热,遍身恶毒,消瘴疠,双单喉蛾及齿痛,切薄片含;磨涂疔疮肿毒。”《广西实用中草药新选》:“治胃痛,外感高热症,接触性皮炎等。”
本发明中,所述青皮,为芸香利植物福橘或朱橘等多种橘类的未成热的果皮或幼果。各种青皮均含挥发油,且多含黄酮甙等。功能主治:疏肝破气,散结消痰。治胸胁胃脘疼痛,疝气,食积,乳肿,乳核,久疟癖块。《本草图经》:“主气滞,下食,破积结及膈气”。《医学启源》:“《主治秘诀》云,厥阴、少阳之分有病用之。破坚癖,散滞气,去下焦诸湿,左胁有积气”。
本发明中,所述紫荆皮,为豆科植物紫荆的树皮,紫荆含鞣质。种子含微量游离的赖氨酸和天门冬氨酸,功能主治:活血通经,消肿解毒。治风寒湿痹,妇女经闭、血气疼痛,喉痹,淋疾,痈肿,癣疥,跌打损伤,蛇虫咬伤。《开宝本草》:“主破宿血,下五淋,浓煮服之。”《滇南本草》:“治筋骨疼痛,风寒湿痹,麻木不仁,瘫痪痿软,暖筋,止腰痛,治妇人血寒腹痛。”《分类草药性》:“治跌打损伤,咽喉、牙痛,女人月经不调,红崩白带,散血止痛,癣疮。”《纲目》:“活血行气,消肿解毒,治妇人血气疼痛,经水凝涩。”
本发明所用试剂和原料均市售可得。
本发明的有益效果在于:本发明的治疗感冒的中药制剂最大程度的减少了药物之间相互拮抗的效果,使药物相互之间具有协同作用。
本发明的治疗感冒的中药制剂的原料包括连翘、黄芩、通草、大戟、白豆蔻、金果榄、青皮和紫荆皮八种中药药材,八种中药药材通过不同的方法对其中的中药药材进行分别处理,通过这种处理方式可以得到中药制剂,可以减少中药制剂对身体的影响,保留对感冒作用力最大的成分,从而快速的治愈感冒,去除全身皆疼,经风,感冒发热带来的全身疼痛等症状。本发明的中药对人体的毒副作用低,安全性高,本技术通过了中药行业顶尖专家鉴定,在原研药的基础上具有突破性的使用价值。
具体实施方式
下面通过实施例的方式进一步说明本发明,但并不因此将本发明限制在所述的实施例范围之中。
实施例1-4的治疗感冒的中药制剂的原料及其含量如表1所示。
表1 实施例的原料及其含量
所述治疗感冒的中药制剂的制备方法为,将所述各原料组份的金银花、连翘、薄荷、荆芥、淡豆豉、黄芩、青皮和紫荆皮混合均匀,粉碎,所述粉碎后的粉末通过的目数为30-40目,加入乙醇溶液回流提取,所述回流提取的时间为2-4小时,乙醇溶液的体积浓度为70-80%,过滤,得到滤液I和滤渣,将所述滤渣和水混合,在50-60摄氏度下浸泡3-4小时,过滤,得到滤液II,将上述得到的滤液I和滤液II混合,得到滤液;将所述原料的其他各组份混合均匀,加入水中,在90-100摄氏度下加热,过滤,得到滤液,将上述得到的滤液混合,按照中药制剂的常规制备方法得到治疗感冒的中药制剂。所述中药制剂的剂型为片剂、胶囊剂、软胶囊剂或颗粒剂。
实施例5
服药方法和疗程:
口服本发明实施例1的中药制剂,每次2次,每次0.2g,一天为一疗程,口服2-7个疗程。
实施例6
本发明的中药制剂还具有在制备治疗哮喘的中药制剂中的应用。
王**,男,南通市人,52岁,疾病发作时伴有咳嗽、咳痰、喘息、呼吸困难、胸闷和胸痛等症状,服用本药后,基本痊愈。
实施例7
治疗感冒的疗效观察实验:
通过使用本发明的治疗感冒的中药制剂中的胶囊剂,治疗感冒患者来证明本发明的中草药组合物的疗效。
材料方法:
病例选择:共50例,随机分成3组,30例使用本发明实施例1的胶囊剂,15例为对照组(服用购自惠州市九惠制药股份有限公司的999感冒灵颗粒),5例基础组(不服用任何药物)。
本发明的50例病人中,年龄为18-70岁,平均年龄为40岁,男女各25名。其中,患者的症状为初起病多急,以鼻部卡他症状和喷嚏、流涕、鼻塞;甚者有:恶风寒,发热,头痛,头昏,咳嗽等等。急性病毒性咽炎以咽部发痒和和咽部灼热感,咽痛可伴有发热头痛、咳嗽乏力等为主要症状。主要急性病毒性喉炎以声嘶、讲话困难、咳嗽时疼痛,常伴有发热、咳嗽等为主要症状。可见鼻腔粘膜充血水肿,有分泌物。咽部轻度充血。病毒性咽炎可见咽部明显充血和水肿,领下淋巴结肿大,并有触痛。而病毒性喉炎检查时可咽喉充血、水肿,局部淋巴结轻度肿大和触痛,还可听到喘息声。
诊断与疗效判定:
三组胃肠病患者均经过胃镜和化验证实。
疗效判定标准:
显效:治疗后症状较治疗前明显减少,各项检查指标基本恢复正常。
有效:治疗后症状有所减少,各项指标改善。
无效:治疗后各症状无明显改善。
结果如表2所示。
表2 对感冒的影响情况表
表3结果显示,
疗效:30例使用本发明的胶囊剂中,显效25例,有效5例,无效0例。其中,显效和有效的比例为100%;对比例1,显效和有效的比例为86.67%。
通过观察服用本发明药物制剂的患者可以知道,服用本发明制剂可有效的治愈感冒,缓减感冒引起的病症。
典型的病例如下:
病例一:刘**,男,29岁,上海市浦东新区人。2014年2月中旬患重感冒,体温达39.2℃,在医院输液4天无效,改服用本中药3天,症状消失,体温恢复至37.8℃,连服4天,病症痊愈。
病例二:陈**,女,36岁,住江苏南通市,2014年3月感觉全身不适,疼痛并伴有头昏、高热等症状,在医院服用过多种中药与西药,高热不退、毫无效果。后改服用本中药3天,症状明显好转,不再高热,身体不适症状明显减轻连服7天,一切正常,痊愈以上。
实施例8
本发明还可以用于麦粒肿、眼睑丹毒、眼睑炎性水肿,眼部带状症状的病人,均作为选择病例的标准,给予治疗。
诊断标准:
经本发明纯中药治疗眼病的制剂治疗后效果明显。
治疗方案:
每日服用1-2次,一次3-5克。以上方法治疗半个月(15天为一疗程)两个疗程后统计疗效。
疗效评定标准:
治愈:根据病情观察,一般1-2疗程可见效果。沙眼、近视眼、斜视、飞蚊症、结膜炎、先天性白内障、远视眼、先天性弱视、青光眼等长期滴入治疗效果佳,有的经过2-3个疗程后,病情立即减轻,慢慢治愈。
所述,仅为本发明的较佳实施例,并非对本发明任何形式上和实质上的限制,应当指出,对于本技术领域的普通技术人员,在不脱离本发明方法的前提下,还将可以做出若干改进和补充,这些改进和补充也应视为本发明的保护范围。凡熟悉本专业的技术人员,在不脱离本发明的精神和范围的情况下,当可利用以上所揭示的技术内容而做出的些许更动、修饰与演变的等同变化,均为本发明的等效实施例;同时,凡依据本发明的实质技术对上述实施例所作的任何等同变化的更动、修饰与演变,均仍属于本发明的技术方案的范围内。
Claims (10)
1.一种治疗感冒的中药制剂,其特征是,所述治疗感冒的中药制剂的原料包括以下成分:金银花、连翘、薄荷、荆芥、淡豆豉、牛蒡子、桔梗、淡竹叶和甘草。
2.如权利要求1所述的治疗感冒的中药制剂,其特征是,所述治疗感冒的中药制剂的原料包括以下重量份的各成分:金银花20份、连翘20份、薄荷12份、荆芥8份、淡豆豉10份、牛蒡子12份、桔梗12份、淡竹叶8份和甘草10份。
3.如权利要求1或2所述的治疗感冒的中药制剂,其特征是,所述治疗感冒的中药制剂的原料还包括以下重量份的各成分:
黄芩15-30份,通草10-20份,大戟10-20份,白豆蔻5-10份,金果榄5-10份,青皮3-5份,紫荆皮1-5份。
4.根据权利要求1或2所述的治疗感冒的中药制剂,其特征是,所述治疗感冒的中药制剂的原料还包括以下重量份的各成分:
黄芩15-20份,通草15-20份,大戟10-15份,白豆蔻5-10份,金果榄5-10份,青皮3-5份,紫荆皮1-5份。
5.根据权利要求1或2所述的治疗感冒的中药制剂,其特征是,所述治疗感冒的中药制剂的原料还包括以下重量份的各成分:
黄芩15-18份,通草18-20份,大戟13-15份,白豆蔻5-8份,金果榄5-8份,青皮3-5份,紫荆皮1-2份。
6.根据权利要求1或2所述的治疗感冒的中药制剂,其特征是,所述治疗感冒的中药制剂的原料还包括以下重量份的各成分:
黄芩18份,通草18份,大戟13份,白豆蔻8份,金果榄5份,青皮3份,紫荆皮2份。
7.一种如权利要求1-6任一项所述的治疗感冒的中药制剂的制备方法,其特征是,步骤为,将所述各原料组份的金银花、连翘、薄荷、荆芥、淡豆豉、黄芩、青皮和紫荆皮混合均匀,粉碎,加入乙醇溶液回流提取,过滤,得到滤液I和滤渣,将所述滤渣和水混合,在50-60摄氏度下浸泡3-4小时,过滤,得到滤液II,将上述得到的滤液I和滤液II混合,得到滤液III;将所述原料的其他组份混合均匀,加入水中,在90-100摄氏度下加热,过滤,得到滤液IV,将上述得到的滤液III和滤液IV混合,按照中药制剂的常规制备方法得到治疗感冒的中药制剂。
8.根据权利要求7所述的治疗感冒的中药制剂的制备方法,其特征是,所述粉碎后的粉末通过的目数为30-40目,乙醇溶液的体积浓度为70-80%,所述回流提取的时间为2-4小时,所述滤渣和水混合,在55-60摄氏度下浸泡3-4小时。
9.根据权利要求7或8所述的治疗感冒的中药制剂的制备方法,其特征是,所述中药制剂的剂型为片剂、胶囊剂、软胶囊剂或颗粒剂。
10.一种如权利要求1-6任一项所述的治疗感冒的中药制剂在制备治疗眼病药物中的应用。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510237745.4A CN104873805A (zh) | 2015-05-11 | 2015-05-11 | 一种治疗感冒的中药制剂、制备方法及应用 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510237745.4A CN104873805A (zh) | 2015-05-11 | 2015-05-11 | 一种治疗感冒的中药制剂、制备方法及应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104873805A true CN104873805A (zh) | 2015-09-02 |
Family
ID=53941660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510237745.4A Withdrawn CN104873805A (zh) | 2015-05-11 | 2015-05-11 | 一种治疗感冒的中药制剂、制备方法及应用 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104873805A (zh) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105770648A (zh) * | 2016-04-07 | 2016-07-20 | 刘爱红 | 治疗感冒的内服中药制剂 |
| CN106563085A (zh) * | 2016-10-28 | 2017-04-19 | 成都鑫瑞现代农业开发有限公司 | 一种金银花感冒茶 |
| CN108210808A (zh) * | 2016-12-09 | 2018-06-29 | 侯春华 | 治疗感冒的内服中药制剂 |
| US20230148646A1 (en) * | 2020-04-24 | 2023-05-18 | Patrick Todorov ANGELOV | Anti-viral, anti-microbial and stimulating immunity food supplement |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101254255A (zh) * | 2008-04-11 | 2008-09-03 | 刘宗升 | 一种治疗感冒的中药制剂 |
| CN103142955A (zh) * | 2013-03-18 | 2013-06-12 | 谢益新 | 一种治疗感冒的药剂 |
| CN103860731A (zh) * | 2014-04-10 | 2014-06-18 | 源西峰 | 一种治疗眼病的纯中药制剂 |
-
2015
- 2015-05-11 CN CN201510237745.4A patent/CN104873805A/zh not_active Withdrawn
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101254255A (zh) * | 2008-04-11 | 2008-09-03 | 刘宗升 | 一种治疗感冒的中药制剂 |
| CN103142955A (zh) * | 2013-03-18 | 2013-06-12 | 谢益新 | 一种治疗感冒的药剂 |
| CN103860731A (zh) * | 2014-04-10 | 2014-06-18 | 源西峰 | 一种治疗眼病的纯中药制剂 |
Non-Patent Citations (2)
| Title |
|---|
| 国家药典委员会: "《中华人民共和国药典 2010年版 一部》", 31 January 2010, 中国医药科技出版社 * |
| 朱东: "《医疗宝典》", 30 September 2009, 广西人民出版社 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105770648A (zh) * | 2016-04-07 | 2016-07-20 | 刘爱红 | 治疗感冒的内服中药制剂 |
| CN106563085A (zh) * | 2016-10-28 | 2017-04-19 | 成都鑫瑞现代农业开发有限公司 | 一种金银花感冒茶 |
| CN108210808A (zh) * | 2016-12-09 | 2018-06-29 | 侯春华 | 治疗感冒的内服中药制剂 |
| US20230148646A1 (en) * | 2020-04-24 | 2023-05-18 | Patrick Todorov ANGELOV | Anti-viral, anti-microbial and stimulating immunity food supplement |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104873805A (zh) | 一种治疗感冒的中药制剂、制备方法及应用 | |
| CN104147572A (zh) | 感冒发热疏风散热制剂及制备方法 | |
| CN104173517B (zh) | 治疗原发性三叉神经痛的中药制剂及制备方法 | |
| CN104147574A (zh) | 治疗感冒发烧的清热解表中药组合物及制备方法 | |
| CN104001045A (zh) | 一种用于治疗犬肺炎的药物及其制备方法 | |
| CN104771578A (zh) | 用于治疗变应性鼻炎的中药 | |
| CN104288394A (zh) | 一种治疗中风、半身不遂的中药组合物 | |
| CN104873693A (zh) | 一种用于止嗽的中药制剂、制备方法及应用 | |
| CN104352880A (zh) | 用于治疗狗细菌感染性感冒的药物组合物及其制备方法 | |
| CN104258252A (zh) | 一种用于治疗鸭病毒性肝炎的药物组合物及其制备方法 | |
| CN105362533A (zh) | 一种小儿泪囊炎护理用泪道冲洗液及其制备方法 | |
| CN105106591A (zh) | 用于治疗牛肺水肿的药物及其制备方法 | |
| CN105169278A (zh) | 一种保肝利胆的蒲公英口服液及其制备方法 | |
| CN104873730A (zh) | 一种治疗肝气郁结型急性乳腺炎的中药及制备方法 | |
| CN104147573A (zh) | 治疗风感头痛的清热解毒制剂及制法 | |
| CN104758668A (zh) | 一种治疗水热蕴结证型臌胀病的中药组合物 | |
| CN104689101A (zh) | 一种治疗隐匿性肾小球肾炎的中药制剂及其制备方法 | |
| CN109106877A (zh) | 一种防治哺乳期妇女热邪壅盛型乳腺炎的中药组合物、其制备方法及药物制剂 | |
| CN108714167B (zh) | 一种治疗白癜风的中药外用制剂及其制备方法 | |
| CN104435853A (zh) | 一种治疗冠心病的中药组合物 | |
| CN105311565A (zh) | 一种防治淋巴癌的中药制剂及制法 | |
| CN106039075A (zh) | 一种治疗肺胃蕴热型慢性咽炎的中药组合物及方法 | |
| CN105412560A (zh) | 一种治疗伤风的药物及其制备方法 | |
| CN105687938A (zh) | 一种用于肛裂的中药制剂及其制备方法 | |
| CN105535895B (zh) | 一种治疗痰咳的中药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20150902 |
|
| WW01 | Invention patent application withdrawn after publication |